JULI SMELSER: Open Payments
NPI 1104075761 · MAUMEE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,074 in 76 payments from 22 companies in 2025. Trend: 2023 $966 · 2024 $1,382 · 2025 $2,074
Food & beverage: $1,884Education: $190
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $493 |
| Regeneron Healthcare Solutions, Inc. | 8 | $304 |
| HARMONY BIOSCIENCES LLC | 7 | $230 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $209 |
| GlaxoSmithKline, LLC. | 14 | $191 |
| GENZYME CORPORATION | 6 | $106 |
| United Therapeutics Corporation | 3 | $65 |
| Baxter Healthcare | 2 | $59 |
| INOGEN, INC. | 2 | $48 |
| Insmed, Inc. | 3 | $46 |
Products named: DUPIXENT, OFEV, BREZTRI, NUCALA, AIRSUPRA, FASENRA, WAKIX, TEZSPIRE.
Industry payments across OH — which companies pay providers there.
